Mereo BioPharma Group plc - stock earnings

MREO Quarterly earnings

DateEarningsRevenue
2023Q2 -17.2 million USD 11.1 million USD
2022Q4 -21.4 million USD ? USD
2022Q3 -7.5 million GBP ? GBP
2022Q2 -9.6 million USD ? USD
2022Q1 -9.6 million USD ? USD
2021Q4 318500 USD ? USD
2021Q3 318500 USD ? USD
2021Q2 6.0 million GBP 18.2 million GBP
2021Q1 6.0 million GBP 18.2 million GBP
2020Q4 -19.5 million GBP ? GBP
2020Q3 -19.5 million GBP ? GBP
2020Q2 -77.2 million USD ? USD
2020Q1 -77.1 million USD ? USD
2019Q4 -24.4 million USD ? USD
2019Q2 -20.6 million USD ? USD
2019Q1 -120.4 million USD ? USD
2018Q4 -19.1 million USD ? USD
2018Q3 -107.4 million USD ? USD
2018Q2 -22.2 million USD ? USD
2018Q1 -9.1 million USD ? USD
2017Q4 -21.6 million USD ? USD
2017Q2 -38.6 million USD ? USD

MREO Yearly earnings

DateEarningsRevenue
2022 -41.4 million USD 1.8 million USD
2021 17.2 million USD 49.3 million USD
2020 -223.7 million USD 537309 USD
2019 -45.7 million USD -159972 USD
2018 -40.7 million USD ? USD
2017 -52.2 million USD -4.4 million USD
2016 -35.0 million USD ? USD
2015 -18.1 million USD ? USD

MREO

Price: $2.94

52 week price:
0.86
4.36

Earnings Per Share: -0.32 USD

P/E Ratio: -12.16

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 278100

Market Capitalization: 439.0 million

Links: